Evans John M. bought BEAM
October 1, 2025 · Form 4 insider transaction
Evans John M. bought 25,000 shares of Beam Therapeutics Inc. at $0.67 per share, a transaction worth $16.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.67
Total value
$16.8K
InsiderEvans John M.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 1, 2025
Filing dateOctober 3, 2025
Shares owned after1,011,667
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.; Includes 418 shares acquired by the Reporting Person under the Beam Therapeutics Inc. ("BEAM") Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2025.